Kynexis

Netherlands - Naarden

Biotechnology

Focus: Small Molecule Brain Disease Therapeutic

Kynexis is a life sciences company focused on Small Molecule Brain Disease Therapeutic.

Neurology

Funding Stage

PUBLIC

Employees

51-200

Open Jobs

Pipeline & Clinical Trials

KYN-5356

Phase 1

Clinical Trials (1)

NCT06225115A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years

Phase 1

KYN-5356 low dose

Phase 2

Clinical Trials (1)

NCT07191483A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Phase 2

No open positions listed yet.

Interview Prep Quick Facts

Founded: 1991

Portfolio: 2 clinical trials